Faculty of Pharmaceutical Sciences

• Collaboration for Outcomes Research and Evaluation
• Molecular and Systems Pharmacology
• Nanomedicine and Chemical Biology
• Pharmacy Education Research and Leadership

By the Numbers

2025 QS World University Rankings, Pharmacy & Pharmacology: #38 Worldwide, #2 in Canada

As of Feb 2025 (from Jan 1, 2024 to Dec 31, 2024)

• Publications: 79
• Grants: 162
• Awards: 65
• Presentations: 61
• Media Hits: 148
• Students
  • E2P PharmD: 868 (2023 Winter Term 2); 647 (2024 Summer Term); 887 (2024 Winter Term 1)
  • Flex PharmD: 11 (2023 Winter Term 2); 6 (2024 Summer Term); 14 (2024 Winter Term 1)
  • BPSc: 189 (2023 Winter Term 2); 85 (2024 Summer Term); 245 (2024 Winter Term 1)
  • GDPL: N/A (2023 Winter Term 2); N/A (2024 Summer Term); 7 (2024 Winter Term 1)
  • MSc: 45
  • PhD: 50
  • Postdoctoral Research Fellows: 22
  • 16,000+ registrants in 52 Continuing Pharmacy Professional Development programs and 60 students in 3 Canadian Pharmacy Practice Program offerings
• Alumni (total): 7,737
• Experiential Education: 865 Practice Educators in 541 Practice Sites
• Practice: 2,057 Patient Encounters (Jan 1, 2024–Dec 31, 2024); 27,656 Patient Encounters (cumulative total through 134 months of operation)
• People: 84 Total FTE Faculty; 716 Clinical Faculty; 14 Honourary Faculty; 99 Total Staff; 4 Research Associates; 149 Student Workers

To view our 2024 Year in Review report, click here (PDF, 11.7 MB).

March 2025

Nicole Kattner, Yan Hang, Nicole A J Krentz, Lydia A Russell, Matthew Palmer, Christine Flaxman, Nadine Plett, Rowan Coulthard, Yara Al-Selwi, Nicola Dyson, Minna Honkanen-Scott, Seung K Kim, Dina Tiniakos, Günter Klöppel, Sarah J Richardson, James A M Shaw. Identification of a vimentin-expressing alpha-cell phenotype in Cystic Fibrosis and normal pancreas. J Endocrinol. 2025 Feb 17;264(3):e240190

Tam ACT, Badesha J, Guh DP, Bansback N, Peter KK, Hollis A, Grootendorst P, Bae SC, Anis AH, Zhang W. Biosimilar policies and their impact on market penetration of adalimumab, etanercept and infliximab: a policy synthesis and descriptive analysis in 13 OECD countries. BioDrugs. doi:https://doi.org/10.1007/s40259-025-00709-1.

Naik H, Zhu B, Er L, Sbihi H, Janjua NZ, Smith PM, Tran K, Levin A, Zhang W. Health-related adverse work outcomes associated with post COVID-19 condition: A cross-sectional study. BMJ Public Health. 2025;3:e001801. doi: https://doi.org/10.1136/bmjph-2024-001801.

Borle, K., Austin, J. & Lynd, L.D. Assessing the prevalence of unmet need for genetic counseling in Canada and exploring associations with sociodemographic factors. European Journal of Human Genetics. (2025). https://doi.org/10.1038/s41431-025-01812-1

Sina Halvaei, Nikki Salmond, & Karla Williams. (2025). Identification of DYRK1b as a novel regulator of small extracellular vesicle release using a high throughput nanoscale flow cytometry screening platform. Nanoscale. https://doi.org/10.1039/D4NR02510E

Laetitia Coassolo, Niels B Danneskiold-Samsøe, Quennie Nguyen... Nicole A J Krentz, Andreas Stahl, Danny Hung-Chieh Chou, Liqun Luo, Katrin J Svensson. Prohormone cleavage prediction uncovers a non-incretin anti-obesity peptide. Nature. 2025 Mar 5. PMID: 40044869

Lishman H, Cragg A, Chuang E, Zou C, Marra F, Grant J, Patrick D, Hohl CM. ICD-10 codes used to identify adverse drug events to antibiotics in administrative data. Antibiotics 2025, 14(3), 314; https://doi.org/10.3390/antibiotics14030314.

Nethery E, Pickerill K, Butska L, Turner M, Hutcheon JA, Janssen P, Schummers L. Perinatal outcomes following non-adherence to guideline-based screening for gestational diabetes in British Columbia, Canada: A population-based cohort study. Acta Obstetricia et Gynecologica Scandinavica. 2025; epub ahead of print March 18. DOI: 10.1111/aogs.15098

Borle, K., Lynd, L.D. & Austin, J. Exploring individuals’ experiences with self-reported unmet need for genetic testing. European Journal of Human Genetics (2025). https://doi.org/10.1038/s41431-025-01838-5

March 2025

CORE PI Jacquelyn Cragg was awarded a renewed Canada Research Chair (CRC; $500,000 over five years)

CORE PI Jacquelyn Cragg received an NSERC PromoScience grant ($148,500) for her science outreach program "Resilience with research: a mentoring program to empower youth victims of violent crime in BC"

Meng Y, Lai T, Tang A. Enhancing Access to Gender Affirming Products through the First Nations Health Authority (FNHA) Benefits Program. $2,000. Trans Care BC, Provincial Health Services Authority. 2025.

Canadian Immunization Research Network (CIRN) - CIHR Grant Funding for 2 years received for "Making healthcare encounters count: a mixed-methods study to identify missed opportunities for vaccination in Ontario." PI: Dr. Shaza Fadel Co-A: F. Lalji, C Ji, E. Di Ruggiero, P. Piche-Renaud, N. Basta, S.Morris, J.Rayner, S.Nasreen, S.Wanigaratne

Ministry of Health Research Seed Grant. Access and Adherence to Smoking Cessation Programs: How are people in BC using community pharmacies? Funding: $72,250. Theresa Charrois, Associate Dean, Practice Innovation, Pharmaceutical Sciences, UBC Vancouver. Kate Johnson, Assistant Professor, Pharmaceutical Sciences, UBC Vancouver. Kevin Duan, Assistant Professor, Faculty of Medicine, UBC Vancouver. Jamie Yuen, Lecturer and Clinical Pharmacist, Pharmaceutical Sciences, UBC Vancouver. Karen Dahri, Associate Professor, Pharmaceutical Sciences, UBC Vancouver. Laura Struik, Assistant Professor, School of Nursing, UBC Okanagan. Femke Hoekstra, Assistant Professor, Faculty of Medicine, UBC Vancouver. Andreas Pilarinos, Regional Lead, Research and Policy, Indigenous Health Research Unit, Vancouver Coastal Health. Phalgun Joshi, Director of Operations, Legacy for Airway Health

Project Title: Beyond Prescriptions: The Role of Community Pharmacists in Providing Non-Pharmacologic Nicotine Cessation Support to British Columbians. Principal Investigator: Karen Dahri, Associate Professor, Pharmaceutical Sciences, UBC Vancouver. This project aims to explore how community pharmacists in British Columbia deliver non-pharmacologic nicotine cessation support and identify the barriers and facilitators influencing their ability to provide this care. Ministry of Health Research Seed Grant program for 2024/25, run in partnership with UBC Health.